Trial Outcomes & Findings for GlideScope Versus Direct Laryngoscope for Emergency Intubation (NCT NCT01235065)

Results Overview

Assessment of whether or not the patient was discharged alive from the study center

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

623 participants

Primary outcome timeframe

2 weeks, on average

Results posted on

2023-06-01

Participant Flow

Participant milestones

Participant milestones
Measure	Direct Laryngoscope emergency intubation with direct laryngoscopy technique type of laryngoscope: Patients who require emergency rapid sequence intubation are randomized to intubation with either the direct laryngoscope or the video laryngoscope	Video Laryngoscope emergency intubation with video laryngoscopy technique type of laryngoscope: Patients who require emergency rapid sequence intubation are randomized to intubation with either the direct laryngoscope or the video laryngoscope
Overall Study STARTED	320	303
Overall Study COMPLETED	320	303
Overall Study NOT COMPLETED	0	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

GlideScope Versus Direct Laryngoscope for Emergency Intubation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Direct Laryngoscope n=320 Participants emergency intubation with direct laryngoscopy technique type of laryngoscope: Patients who require emergency rapid sequence intubation are randomized to intubation with either the direct laryngoscope or the video laryngoscope	Video Laryngoscope n=303 Participants emergency intubation with video laryngoscopy technique type of laryngoscope: Patients who require emergency rapid sequence intubation are randomized to intubation with either the direct laryngoscope or the video laryngoscope	Total n=623 Participants Total of all reporting groups
Age, Continuous	43 years n=5 Participants	42 years n=7 Participants	43 years n=5 Participants
Sex: Female, Male Female	76 Participants n=5 Participants	87 Participants n=7 Participants	163 Participants n=5 Participants
Sex: Female, Male Male	244 Participants n=5 Participants	216 Participants n=7 Participants	460 Participants n=5 Participants
Region of Enrollment United States	320 Participants n=5 Participants	303 Participants n=7 Participants	623 Participants n=5 Participants

PRIMARY outcome

Timeframe: 2 weeks, on average

Assessment of whether or not the patient was discharged alive from the study center

Outcome measures

Outcome measures
Measure	Direct Laryngoscope n=320 Participants emergency intubation with direct laryngoscopy technique type of laryngoscope: Patients who require emergency rapid sequence intubation are randomized to intubation with either the direct laryngoscope or the video laryngoscope	Video Laryngoscope n=303 Participants emergency intubation with video laryngoscopy technique type of laryngoscope: Patients who require emergency rapid sequence intubation are randomized to intubation with either the direct laryngoscope or the video laryngoscope
Number of Participants Who Survived to Hospital Discharge	296 Participants	275 Participants

SECONDARY outcome

Timeframe: Up to 100 seconds

How long (seconds) it takes the provider to perform the intubation procedure.

Outcome measures

Outcome measures
Measure	Direct Laryngoscope n=296 Participants emergency intubation with direct laryngoscopy technique type of laryngoscope: Patients who require emergency rapid sequence intubation are randomized to intubation with either the direct laryngoscope or the video laryngoscope	Video Laryngoscope n=275 Participants emergency intubation with video laryngoscopy technique type of laryngoscope: Patients who require emergency rapid sequence intubation are randomized to intubation with either the direct laryngoscope or the video laryngoscope
Length of Time to Perform the Intubation Procedure	40 seconds Interval 24.0 to 68.0	56 seconds Interval 40.0 to 81.0

Adverse Events

Direct Laryngoscope

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Video Laryngoscope

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dale Yeatts, Principal Investigator

R Adams Cowley Shock Trauma Center

Phone: 443-909-0648

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place